Neuromuscular

Episodes 17-20 of 20

• 

  RestartResume

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  RestartResume

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  MinuteCE®

  The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  RestartResume

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  MinuteCE®

  FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  RestartResume

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  MinuteCE®

  Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

• 

  RestartResume

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  RestartResume

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  MinuteCE®

  Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies 

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit

  Nicholas J. Silvestri, MD; James F. Howard, Jr, MD

  1.00 program credit